Lichen sclerosus is driven primarily by an autoimmune process, but no single cause fully explains the condition. Instead, a combination of immune system dysfunction, genetic susceptibility, hormonal shifts, and environmental triggers appears to set the disease in motion. It is not contagious and not sexually transmitted.
The Autoimmune Connection
The strongest evidence points to the immune system attacking a specific protein in the skin called extracellular matrix protein 1 (ECM1). This protein acts like structural glue, helping maintain the normal architecture of skin tissue. In a study published in The Lancet, about 74% of people with lichen sclerosus had antibodies targeting ECM1. When the immune system generates these antibodies and they bind to ECM1 in the skin, the result is chronic inflammation that gradually breaks down and scars the tissue.
This autoimmune basis also explains why lichen sclerosus frequently shows up alongside other autoimmune conditions. People with lichen sclerosus are roughly 2.4 times more likely to have autoimmune thyroid disease than the general population. The overlap suggests a shared pattern of immune dysregulation rather than a problem isolated to the skin.
Genetic Susceptibility
Lichen sclerosus clusters in families, and specific immune-system genes help explain why. Researchers have identified several HLA markers (genes that shape how your immune system recognizes threats) that appear more frequently in affected families. The marker DQ7 shows the strongest association, along with variants called DRB1*04 and DRB1*07. Notably, some of these same genetic markers are also linked to autoimmune thyroid disease, which reinforces the idea of a shared genetic vulnerability across conditions.
Having these genes doesn’t guarantee you’ll develop lichen sclerosus. They raise the baseline risk, but something else, whether hormonal, environmental, or immunological, typically needs to tip the balance.
Hormonal Factors
The age pattern of lichen sclerosus offers a strong clue about hormones. The condition peaks in two groups: prepubescent girls (about 1 in 900) and women who are perimenopausal or postmenopausal (between 1 in 1,000 and 1 in 60). Both groups share one thing in common: low estrogen levels. This has led researchers to suspect that estrogen insufficiency creates conditions in vulvar skin that make it more vulnerable to immune-driven damage.
Androgen metabolism may also play a role. Women with untreated lichen sclerosus have been found to have significantly lower levels of certain androgens (dihydrotestosterone and androstenedione) compared to age-matched controls, alongside reduced androgen receptors in affected skin. Some research suggests that oral contraceptive pills with anti-androgenic properties may trigger early onset in a small number of sensitive younger women by disrupting the androgen-dependent maintenance of vulvar skin.
The hormonal picture remains incomplete, though. Topical testosterone treatments, once widely used, were later shown in controlled trials to be ineffective. And estrogen receptor levels in affected tissue don’t actually differ from healthy tissue. So while hormonal shifts clearly correlate with disease onset, they likely act as a contributing factor rather than a standalone cause.
Physical Trauma and the Koebner Phenomenon
Lichen sclerosus can develop in skin that has already been damaged, a pattern called the Koebner phenomenon. Surgical scars, friction injuries, and other forms of skin trauma have all been identified as possible triggers in people who are genetically predisposed. This means that in some cases, the location where lichen sclerosus first appears isn’t random. It follows the site of prior injury.
This phenomenon also helps explain why the condition so often affects genital skin, an area subject to regular friction and mechanical stress. The combination of vulnerable tissue and ongoing low-level trauma may create the conditions for an autoimmune response to take hold.
Infection as a Possible Trigger
Since the late 1980s, researchers have investigated whether the bacterium that causes Lyme disease (Borrelia burgdorferi) could trigger lichen sclerosus. Early studies detected the bacterium frequently in new lichen sclerosus lesions, suggesting it might initiate the inflammatory cascade. However, follow-up studies using different detection methods have produced conflicting results, and no consensus exists. The current thinking is that if Borrelia plays a role at all, it likely acts as an initial trigger in some cases rather than an ongoing infection driving the disease.
How Oxidative Stress Drives Tissue Damage
Once lichen sclerosus is established, oxidative stress becomes a major force in how the disease progresses and causes lasting damage. Oxidative stress occurs when harmful molecules called free radicals overwhelm the body’s ability to neutralize them. In lichen sclerosus lesions, researchers have found high concentrations of lipid peroxidation products (damaged fats) in the deepest layers of the outer skin, along with evidence of oxidative DNA damage in all examined lesions and oxidative protein damage in areas of scarring.
This oxidative damage is likely the most significant driver of the fibrosis, or scarring, that defines advanced lichen sclerosus. As tissue breaks down and attempts to repair itself, the cycle of damage and regeneration thickens and stiffens the skin. Over time, this scarring can bury the clitoris, narrow the vaginal opening, cause pain during intercourse, or in men lead to tightening of the foreskin. The persistent DNA damage from oxidative stress also contributes to a small but real risk of malignant transformation in long-standing lesions.
How Early and Late Disease Differ
In its earliest stages, lichen sclerosus can be easy to miss. The first sign is often just mild redness, particularly in the genital or anal area. In children, slight redness followed by loss of skin color may be the only visible change. Early lesions often look nonspecific, which is one reason the condition is frequently diagnosed late.
As the disease progresses, the hallmark white, shiny patches develop. These spots may merge into larger areas that resemble wrinkled parchment or tissue paper. In later stages, the chronic inflammation and oxidative damage produce scarring that can narrow the urethral opening in men, fuse the labia in women, or cause painful bowel movements if perianal skin is affected. The progression from redness to visible scarring can take months to years, and the earlier treatment begins, the more effectively scarring can be prevented.